MemorEM 1000

DEVICE2 trials

Sponsors

NeuroEM Therapeutics, Inc.

Conditions

Alzheimer DiseaseAlzheimer Disease, Late Onset

Unknown Phase

Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease

CompletedNCT02958930

NeuroEM Therapeutics, Inc.Alzheimer Disease, Alzheimer Disease, Late Onset

Start: 2017-10-01End: 2019-01-11Updated: 2019-04-23

Transcranial Electromagnetic Treatment Against Alzheimer's Disease

CompletedNCT03927040

NeuroEM Therapeutics, Inc.Alzheimer Disease, Alzheimer Disease, Late Onset

Start: 2019-04-15End: 2020-10-30Updated: 2025-05-22

Related Papers

Transcranial Electromagnetic Treatment “Rebalances” Blood and Brain Cytokine Levels in Alzheimer’s Patients: A New Mechanism for Reversal of Their Cognitive Impairment

Frontiers in Aging Neuroscience2022-05-0216 citations